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The Simpson atherectomy catheter was used to treat 60 
patients with a total of 94 lesions comprising 63 stenoses 
(mean length 1.1 + 0.5 cm) and 31 occlusions (4.2 f 2.9 
cm) of the superficial femoral (n = 77), popliteal (n = S), 
iliac (n = 8) and anterior tibia1 (n = 1) arteries. The 
immediate angiographic success rate was 90% for both 
occlusions and stenoses, and clinical success was obtained in 
82 % of patients. The stenoses were reduced from 83 + 13 % 
to 17 f 18% acutely and to 31 f 26% at 6 months; the 
occlusions were reduced from 100% to 9 f 9% initially and 
to 60 f 34% at 6 months. 
Angiographic restenosis was found in 24% of lesions: 
The percutaneous treatment of vascular disease with balloon 
angioplasty may be limited by acute reocclusion and the 
relatively high long-term restenosis rate after a primary 
successful intervention (l-4). For these reasons, new tech- 
niques using either mechanical (5-7) or other (8-10) energy 
forms that attempt to remove obstructive plaque material are 
being developed. We previously reported (11) encouraging 
initial results with the Simpson peripheral atherectomy cath- 
eter (12,13), and now present long-term clinical and angio- 
graphic results in 60 patients with symptomatic peripheral 
vascular disease. 
Methods 
Study patients. A total of 60 patients (48 male, 12 female, 
mean age 64.1 ? 10.6 years) with symptomatic disease were 
accepted for atherectomy. Patient characteristics are de- 
scribed in Table 1; 15 patients (25%) had rest pain and 6 
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23% in concentric and 11% in eccentric lesions and 47% in 
total occlusions. At 1 year, 72% of patients had clinically 
patent arteries with maintained Doppler index and walking 
distance. Three of four patients undergoing repeat atherec- 
tomy had a second restenosis. 
In summary, the procedure was found to be safe and 
effective in the treatment of peripheral vascular disease. It 
appears to be particularly beneficial in the treatment of 
eccentric stenoses and is not limited by the presence of 
calcification. 
(J Am Co11 CardiolI990;15:682-8) 
(10%) had gangrene. The majority of patients were referred 
because of the complexity of the lesion or because they were 
considered poor surgical candidates as a result of poor distal 
vessels, with limb salvage as the main goal in three patients. 
Clinical evaluation and follow-up. All patients underwent 
baseline Doppler study with calculation of the leg/arm index 
and standardized claudication-limited walking distance eval- 
uation (3 km/h, 12.5% incline, maximal 250 m). Although a 
learning effect on the treadmill cannot be excluded, all 
variables were repeated on the second day after the proce- 
dure, as well as after 1, 3 and 6 months, at which time a 
control angiogram was also performed (or sooner if dictated 
by symptoms), and biannually thereafter. Patients with 
evidence of vascular noncompressibility during Doppler 
pressure testing were excluded from the Doppler index 
analysis, although they were included in other study analy- 
ses. All patients were treated with 500 mg of aspirin before 
the procedure, and continued on aspirin therapy for 6 
months after the procedure. Most patients were discharged 
within 48 h of the procedure. 
Atherectomy procedure. The intervention was performed 
as previously described (11). All patients gave informed 
consent and the protocol was approved by the ethics com- 
mittee of the university. The Simpson catheter has a 4.5 cm 
guide wire at its distal end, and its metal housing incorpo- 
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Table 1. Clinical Characteristics of 60 Patients Undergoing 
Peripheral Atherectomy 
Age (yr) 
Male/female 
Rest painigangrene 
Smoker 
Hypertension 
Hypercholesterolemia 
Diabetes 
Coronary heart disease 
Previous peripheral balloon angioplasty of 
atherectomized lesion 
64.1 2 10.6 
48112 
1516 
79.7% 
12.9% 
S2.5% 
2X.8% 
69.5% 
13.6% 
rates a rotary knife (2,000 rpm) that is battery powered and 
under operator control. All patients underwent percutaneous 
puncture for access; in no case was a surgical cutdown 
procedure employed. 
AfterJluoroscopic localization of the lesion, the atherec- 
tomy catheter (7F to 11F) was introduced and the window in 
the housing was directed toward the aspect of the lesion to 
be excised. A low pressure (2 to 3 atm) balloon was used to 
maintain the selected orientation. As the cutting edge was 
advanced, slices of material protruding into the opening in 
the housing were shaved off and trapped in a collecting 
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chamber. Passes of the cutter were continued, with adjust- 
ment of position as necessary until no or minimal residual 
stenosis and good contrast density were achieved. Excised 
plaque material was submitted for histologic examination 
(14.15) and cell culture study (16,17). 
In cases of total occlusion, the procedure was modified in 
the following stepwise fashion. An effort was made to 
penetrate the occlusion mechanically, using either a guide 
wire, the angioscope, the inner stylet of the introducer 
sheath (USCI) or other catheter as a “Dotter” instrument 
(Fig. 1). After creation of a narrow channel, an attempt was 
made to introduce the atherectomy catheter. If this was not 
feasible, balloon angioplasty was performed with the goal of 
creating a lumen large enough to allow passage of the 
atherectomy catheter, but not achieve maximal dilation 
effect. Once introduced, the atherectomy catheter was used 
Figure 1. Stepwise reconstruction of a total occlusion of the super- 
ficial femoral artery (upper panel, left). Recanalization under angio- 
scopic guidance (angioscope housed within a catheter) resulted in a 
narrow irregular channel (upper panel, right). The atherectomy 
catheter could then be passed, with initial partial improvement 
(lower panel, left) and final complete reconstruction by the removal 
of obstructive material (lower panel, right). 
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Table 2. Angiographic Success, Defined as a Residual Stenosis of 
-30%. After Atherectomv in 94 Lesions (60 Datientsl 
Vessel 
Iliac 
Femoral 
Popliteal 
Tibia1 
Total 
Stenoses (n = 63) 
(mean length 1.1 + 0.5 cm) 
4/a (50%) 
51/53 (96%) 
l/l (100%) 
l/l (100%) 
57163 (90%) 
Occlusions (n = 31) 
(mean length 4.2 2 2.9 cm) 
- 
21/24 (88%) 
7/7 (loo%) 
- 
28/31 ( 90%) 
to remove the disrupted stenotic material or “cut” back into 
the lumen from within a dissection. Cases in which angio- 
plasty was considered necessary after atherectomy (residual 
diameter stenoses >50%) were considered to be atherec- 
tomy failures. 
All patients received 5,000 IU of intraarterial heparin at 
the beginning of the procedure, with additional doses of up 
to a total of 10,000 IU based on elapsed time. To maximize 
blood flow, all sheaths were withdrawn at the end of the 
procedure, with manual compression applied for hemostasis. 
Angioscopy. In 60% of treated lesions, an American 
Edwards angioscope was introduced and, as previously 
described (18), used to inspect the treated site. Although 
angiographic results may be satisfactory, angioscopy can 
sometimes detect residual obstructive material or large flaps, 
which can be removed with additional passes of the atherec- 
tomy catheter. 
Definitions. Angiographic success was defined as 
achievement of a residual stenosis of ~50%. Clinical success 
was defined as sustained improvement of symptoms by at 
least one Fontaine class (19) or an increase in the Doppler 
index >O. 15. Duration of occlusion is difficult to assess and 
should be considered an approximation. When possible, it 
was based on angiographic evidence (previous study avail- 
able) or the development of a marked deterioration of 
symptoms. 
Statistics. The paired Student’s t test and Mann-Whitney 
tests were used to calculate quantitative differences before 
and after the procedure and between groups. The chi-square 
test was used to calculate qualitative differences. Signifi- 
cance was based on p values ~0.05. Results are expressed as 
mean values t 1 SD. 
Results 
Angiographic findings (Table 2). Sixty patients with a 
total of 94 lesions in 65 limbs underwent atherectomy (77 
femoral, 8 iliac, 8 popliteal and 1 anterior tibial). Sixty 
lesions (63%) were calcified, 48 (51%) were eccentric, 31 
(33%) were totally occluded and 15 (16%) were concentric. 
Angiographic success (residual stenosis ~50%) (Table 2) 
was achieved in 85 (90%) of 94 lesions, or in 56 (85%) of 65 
limbs. 
Stenoses (Tables 2 and 3). Fifty-seven (90%) of 63 steno- 
ses (mean length 1.1 -t 0.5 cm) were successfully treated 
(Table 2). In three of eight iliac stenoses, adequate stenosis 
reduction could not be achieved despite use of an 11F 
catheter. In an additional patient, the proximity of the iliac 
stenosis to the introducer sheath caused technical diffi- 
culties; the sheath was dislodged and the procedure termi- 
nated before effective plaque removal could be achieved. In 
the superficial femoral artery, initial success was attained in 
51 (96%) of 53 stenoses; in one patient, adequate results 
were not obtained in an eccentric stenosis just proximal to an 
area of aneurysmal dilation and, in a second patient, the 
sheath could not be safely introduced probably because of a 
heavily calcified vessel. Examples of concentric and eccen- 
tric stenoses are shown in Figures 2 and 3. 
For the 61 stenoses in which atherectomy was performed 
(excluding the 2 lesions that could not be reached because of 
access problems), the mean percent stenosis of 83 + 13% 
was reduced to 17 ? 18%. There was no significant differ- 
ence between concentric and eccentric stenoses (Table 3). In 
addition, the presence of calcification did not preclude the 
achievement of a low postprocedure residual stenosis. 
Occlusions (Tables 2 and 3). Thirty-one occlusions (mean 
length 4.2 ? 2.9 cm; 23 [74%] calcified) judged to have been 
occluded for 19 2 22 months (range 1 week to 6 years) were 
treated, with success in 21 of 24 femoral and 7 of 7 popliteal 
lesions, for a total initial success rate of 90% (Table 2). The 
mean postprocedure residual stenosis was 9 ? 9%. In 17 
(61%) of 28 occlusions, an initial Dotter technique was 
followed directly by atherectomy; in 11 (39%) of 28, balloon 
angioplasty was first required to allow passage of the stiffer 
atherectomy catheter. 
All three failures resulted from inability to cross the 
occlusion (4, 9 and 10 cm in length, respectively) and 
established continuity with the distal vessel; two of these 
three occlusions were clinically assessed to be >l year old. 
Complications. There was no instance of vessel perfora- 
tion, acute occlusion or emergency surgical intervention. 
One patient undergoing atherectomy of an iliac stenosis had 
a distal embolus to the bifurcation of the anterior and 
posterior tibia1 artery, but had no long-term sequelae. In 
addition, two patients undergoing a second atherectomy for 
restenosis had groin hematomas requiring surgical evacua- 
tion on the third and the sixth day, respectively, after the 
procedure. Local dissections are often seen angiographically 
after crossing total occlusions, but they appear to be of no 
acute consequence. 
Clinical results. Clinical success occurred in 49 (82%) of 
the 60 patients. One patient with an angiographically suc- 
cessful atherectomy of a total occlusion had only transient 
improvement and underwent bypass surgery 2 weeks later. 
In patients with a completed procedure, the mean Doppler 
index improved significantly from 0.59 + 0.18 to 0.83 2 0.17 
in 59 limbs that could be evaluated. A parallel improvement 
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Figure 2. Concentric high grade stenosis of the superficial femoral 
artery before (A) and after (B) two passes of the atherectomy 
catheter, with relief of collateral flow. 
was found in walking distance. which increased from 81.4 t 
63.7 to 161.6 2 82.8 m. 
The ej’fect of the residual stenosis immediately after 
atherectomy on the occurrence of restenosis is difficult to 
evaluate in our series because the majority of successfully 
treated lesions showed angiographic residual stenoses of 
~30% and only four lesions had a residual stenosis >30%. 
There was a borderline significant correlation between the 
number of patent vessels below the trifurcation and the 
6 month stenosis (0 vessels: 17 2 12% stenosis [n = 41; 
1 vessel: 49 + 33% stenosis [n = 121; 2 vessels: 53 2 34% 
stenosis [n = lit]: 3 vessels: 29 ? 20% stenosis [n = 121 [p = 
0.05 between 2 and 3 patent vessels]). The effect of aspirin 
therapy is difficult to evaluate because ~85% of patients 
continued to take aspirin for 6 months. 
Histologic findings. Macroscopically, excised material Clinical patency at 6 months. The rate of lesions that were 
ranged from shiny white to pale yellow in appearance, with clinically patent at 6 months is higher than the rate of 
a mean length of 4.9 ? 2.4 mm. Microscopic evaluation of angiographically documentable patent lesions because six 
305 specimens from 52 lesions showed a thickened, fibrotic patients (four with total occlusions, two with stenoses) 
intima in 100% of stenoses; areas with marked “myointimal exhibited clinical patency and refused repeat angiography. If 
proliferation” were found in 35% of these primary stenoses. these “clinically patent” results were considered with the 
Sections of media were found in 55% of stenoses, but none known angiographic results, the restenosis rates would be as 
showed adventitia. Fresh or organized thrombus material follows: all lesions, 13 (21%) of 61; concentric stenoses, 
was found in 75% of stenoses, and the classic atheromatous 3 (21%) of 14. eccentric stenoses, 3 (11%) of 28 and total 
bed with cholesterol crystals could be detected in only 5.8% occlusions, 7 (37%) of 19. 
of cases, All seven restenoses evaluated showed a thickened 
fibrotic intima; marked cellular proliferation and organized 
thrombus were found and media was reached in six of seven 
cases (15). 
Long-Term Patency 
Six month angiography (Table 3). A 6 month control 
angiographic study was performed on 55 primary lesions 
(87% of the 63 lesions due for 6 month study); the mean 6 
month percent stenosis for all lesions was 39%. Although 
there is a trend for a higher residual stenosis for concentric 
as compared with eccentric stenoses, this difference was not 
significant (44 2 28% versus 27 t 26%) (Table 3). Cases of 
total occlusion showed a significantly higher 6 month mean 
percent stenosis of 60 2 34%. 
Restenosis. Angiographic restenosis, defined as >50% 
reduction in luminal diameter, was found in 13 (24%) of 55 
lesions. When analyzing for primary morphology, restenosis 
was found in 3 (23%) of 13 concentric lesions, 3 (11%) of 27 
eccentric lesions and 7 (47%) of 15 total occlusions studied. 
Two patients with documented angiographic restenosis had 
had no clinical signs of restenosis. Interestingly, three pa- 
tients (with a total of seven treated lesions) showed clinical 
signs of restenosis, but were all found to have good angio- 
graphic results of their atherectomized lesions. One patient, 
however, was found to have a new iliac stenosis that was 
treated with balloon angioplasty. Two patients showed a 
new lesion or progression of a lesion in the proximal super- 
ficial femoral artery, perhaps related to the introducer 
sheath. 
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Figure 3. Eccentric stenosis of the superficial femoral artery before 
(A) and after(B) atherectomy. The window in the housing is directed 
toward the eccentric aspect of the lesion, and selective passes are 
made. 
One year follow-up. Twenty-five patients who had an 
initially successful intervention have now reached the 1 year 
follow-up period, and in 18 (72%) their artery remains 
clinically patent, 4 (16%) have undergone repeat atherec- 
tomy and 2 (8%) have undergone surgical intervention (Fig. 
4). Of the four patients who underwent repeat atherectomy, 
three had a second restenosis; two underwent surgery and 
one had a third atherectomy (and continues to have a 
clinically patent artery at 2 years). To date, only one patient 
has developed a restenosis after 6 months and the mean 
Doppler index and walking distance have been maintained 
up to 2 years (1 year: 0.78 index [n = 151 and 160.5 m [n = 
111, respectively; 2 years: 0.91 index [n = 81 and 188.7 m 
[n = 71, respectively). 
Discussion 
Immediate results. Percutaneous atherectomy with the 
Simpson atherectomy catheter in patients with peripheral 
vascular disease allows a high initial success and low com- 
plication rate. This applies to eccentric and concentric 
stenosis, as well as total occlusion. In addition, heavy 
calcification (as seen fluoroscopically) has not hindered 
results. Markedly irregular, eccentric lesions or longer oc- 
clusions may be more difficult to treat with angioplasty 
alone, and the removal of plaque material with this atherec- 
tomy catheter enables a favorable immediate angiographic 
result. Significantly, there was no incidence of procedure- 
related acute occlusion or vessel perforation. The treatment 
of iliac vessels, despite an 11 French catheter, is somewhat 
limited by the size of the vessel and is inferior to results with 
conventional angioplasty. 
Restenosis. The angiographic restenosis rate of 15% for 
stenoses is comparable with that reported for balloon angio- 
plasty, but may be affected by the fact that 13% of patients 
had previous balloon angioplasty and, thus, were at greater 
Table 3. Angiographic Results in 61 Stenoses and 28 Total Occlusions in Which the Atherectomy 
Procedure Was Completed 
Immediately After 6 Months After 
Before Atherectomy Atherectomy Atherectomy 
% % % 
No. Stenoses No. Stenoses No. Stenoses 
All stenoses 61 83 + 13 61 17 2 18 40 31 +26 
Concentric 15 85 ? 12 15 17 ? 12 13 44 + 28 
Eccentric 46 82 + 13 46 17 k 17 27 27 + 25 
Calcified 33 85 ” 13 33 19 It 21 18 35 2 20 
Occlusions 28 100 28 9*9 15 60 ? 34* 
*p < 0.05 compared with stenoses. Data are reported as mean values + SD. 
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patent 
n=25 patients 
surgery 
8% 
repeat atherectomy 
non-patent 
4% 
16% 
Figure 4. One year follow-up data in 25 patients after successful 
atherectomy; 18 patients exhibit clinical patency, 4 have undergone 
repeat atherectomy, 2 have undergone a surgical procedure and I 
patient with clinical restenosis remains in stable condition without 
further intervention. 
risk for restenosis. On the other hand, relatively short 
stenoses were treated in this series. High grade eccentric 
lesions, with a 12% angiographic restenosis rate, appear to 
be particularly amenable to treatment with directional 
atherectomy. Although good immediate results were 
achieved in short and moderate length total occlusions by 
the combination of recanalization and plaque removal with 
atherectomy, the restenosis rate remains high (47%). The 
almost complete angiographic follow-up data obtained in this 
study, however, makes the results somewhat difficult to 
compare with clinical patency rates usually reported after 
balloon angioplasty (l-4,10). It should be emphasized, how- 
ever, that it is not our intent to compare atherectomy with 
angioplasty, but rather to define areas where atherectomy 
may be applicable. Only a randomized trial can compare 
results in a meaningful way. 
There was no associatiorl between residual angiographic 
stenosis and the occurrence of restenosis, as reported by 
Simpson et al. (12), perhaps because the majority of our 
procedures resulted in ~30% residual stenosis and angios- 
copy was often used to inspect the treated region and guide 
optimal reconstruction. 
Other methods. Long-term results after treatment with 
other rotational devices (5~3) that are currently being used in 
peripheral vessels are not yet available and, therefore, direct 
comparisons are not possible. Recently published results 
(9,lO) after laser therapy for total occlusions in 
the peripheral circulation appear promising and this ap- 
proach may prove advantageous. It must be stressed, how- 
ever, that the Simpson atherectomy catheter is not designed 
for the recanalization of occluded vessels, but is used 
adjunctively after recanalization to remove obstructive ma- 
terial and establish a maximal smooth reconstruction of the 
lumen. 
Implications. The finding of two new stenoses in the area 
of the inserted introducer sheaths is worrisome and empha- 
sizes the extreme care necessary in handling these often 
diffusely altered vessels. In addition, in a limited number of 
patients, we found that a second atherectomy procedure is 
associated with a higher rate of complications (significant 
hematoma) and restenosis. 
The key to better long-term results after percutaneous 
intervention probably lies in better medical prophylaxis, 
regardless of the approach used. In this regard, the actual 
removal of plaque material allowed by this system (in effect 
a vessel wall biopsy) may prove helpful in the study of the 
process of restenosis. Our group and others are performing 
histologic (15) and electron microscopic (16) evaluation of 
removed material and cell culture studies (17,lS) that may 
provide a model for the study of restenosis and its pharma- 
cologic prevention. 
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